Cargando…
Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial (23)Na-MRI investigation
BACKGROUND: Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognosis, with increased morbidity and mortality. Due to limited therapeutic strategies...
Autores principales: | Moosmann, Julia, Toka, Okan, Linz, Peter, Dahlmann, Anke, Nagel, Armin M., Schiffer, Mario, Uder, Michael, Cesnjevar, Robert, Dittrich, Sven, Kopp, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053834/ https://www.ncbi.nlm.nih.gov/pubmed/33948157 http://dx.doi.org/10.1177/20406223211004005 |
Ejemplares similares
-
Lymphocyte Immune Response and T Cell Differentiation in Fontan Patients with protein-losing enteropathy
por: Moosmann, Julia, et al.
Publicado: (2021) -
Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?
por: Lenz, Dominik, et al.
Publicado: (2003) -
Protein-Losing Enteropathy: A Big Challenge in Fontan Circulation
por: Lee, Jae Young
Publicado: (2022) -
Correction: Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?
por: Lenz, Dominik, et al.
Publicado: (2003) -
First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery
por: Kerling, Anne, et al.
Publicado: (2019)